| +0.18 / +0.31%|
The 20 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 57.50, with a high estimate of 66.00 and a low estimate of 36.00. The median estimate represents a -2.19% decrease from the last price of 58.79.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.